IE
CABA icon

Israel Englander’s Cabaletta Bio CABA Stock Holding History

Israel Englander’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-50,000
Closed -$555K – 6552
2021
Q1 		$555K Buy
+50,000
New +$611K ﹤0.01% 4740

Other funds holding CABA

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Israel Englander's CABA Position: Q2 2026 in Review

Israel Englander reduced its Cabaletta Bio (CABA) stake by 65% in Q2 2026, selling an estimated $12.6M and leaving 2,068,491 shares worth $6.43M. The position accounts for ﹤0.01% of the portfolio, ranked #2750.

Israel Englander first reported a position in CABA in Q4 2019 and has held it in 25 quarters since. The position peaked at $15.9M in Q1 2026. 140 funds tracked by Wall St. Rank hold CABA as of Q2 2026.

  • Israel Englander held 2,068,491 shares of Cabaletta Bio worth $6.43M as of Q2 2026.
  • Israel Englander sold 3,834,790 Cabaletta Bio shares in Q2 2026, an estimated $12.6M.
  • Cabaletta Bio made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #2750 holding.
  • Israel Englander first reported a position in Cabaletta Bio in Q4 2019 and has held it in 25 quarters since.
  • Israel Englander's Cabaletta Bio position peaked at $15.9M in Q1 2026.
  • 140 funds tracked by Wall St. Rank held Cabaletta Bio as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.